1 Day TAK 0.20% DJIA 0.08% S&P 500 0.08% Health Care/Life Sciences 0.13% ...

After hours: March 21 at 7:58:19 PM EDT Loading Chart for TAK ...

3382.T Seven & i Holdings Co., Ltd.

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...

Takeda has announced a $100 million collaboration with Abingworth to work with GammaDelta Therapeutics, a UK biotech which is pioneering a novel type of T cell therapy. The Japanese pharma company ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

As of 1:26:49 p.m. EDT. Market Open. Loading Chart for TAK ...